PUMA BIOTECHNOLOGY, INC.
PBYIUS売上高
$228M
百万USD
営業利益
$37M
百万USD
純利益
$31M
百万USD
ROE
23.9%
最新FY
EPS
$0.61
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $98M | $17M | $0.40 |
| FY2021 | Q2 | $53M | $-5M | $-0.13 |
| FY2021 | Q3 | $46M | $-45M | $-1.09 |
| FY2021 | FY | $253M | $-29M | - |
| FY2022 | Q1 | $53M | $1M | $0.03 |
| FY2022 | Q2 | $60M | $9M | $0.21 |
| FY2022 | Q3 | $57M | $-0M | $-0.01 |
| FY2022 | FY | $228M | $0M | $0.00 |
| FY2023 | Q2 | $55M | $2M | $0.05 |
| FY2023 | Q3 | $56M | $6M | $0.12 |
| FY2023 | FY | $236M | $22M | $0.45 |
| FY2024 | Q1 | $44M | $-5M | $-0.10 |
| FY2024 | Q2 | $47M | $-5M | $-0.09 |
| FY2024 | Q3 | $81M | $20M | $0.41 |
| FY2024 | FY | $230M | $30M | $0.62 |
| FY2025 | Q1 | $46M | $3M | $0.06 |
| FY2025 | Q2 | $52M | $6M | $0.12 |
| FY2025 | Q3 | $54M | $9M | $0.17 |
| FY2025 | FY | $228M | $31M | $0.61 |
| FY2026 | Q1 | $45M | $-4M | $-0.07 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $251M | $272M | $225M | $253M | $228M | $236M | $230M | $228M |
| 営業利益 | $-277M | $-292M | $-95M | $-39M | $-30M | $1M | $24M | $33M | $31M | $37M |
| 純利益 | $-276M | $-292M | $-114M | $-76M | $-60M | $-29M | $0M | $22M | $30M | $31M |
| 総資産 | $253M | $166M | $259M | $235M | $244M | $227M | $222M | $231M | $213M | $216M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $210M | $53M | $34M | $17M | $-6M | $-2M | $22M | $53M | $92M | $130M |
| 営業CF | - | - | $-24M | $22M | $1M | $21M | $-16M | $27M | $39M | $42M |
| EPS | - | - | - | - | - | - | $0.00 | $0.45 | $0.62 | $0.61 |
| BPS | $5.68 | $1.41 | $0.89 | $0.44 | $-0.15 | $-0.06 | $0.46 | $1.11 | $1.86 | $2.56 |
| ROE | -131.5% | -547.7% | -331.1% | -432.9% | 1008.1% | 1190.8% | 0.0% | 40.4% | 32.9% | 23.9% |